DBV Technologies S.A. (DBVT) income statement
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$9.68−0.31 (-3.10%)
Close on Nov 18, 2026Market cap $608.66MP/E –Yield –
DBV Technologies S.A. financial ratios
See a number that looks wrong?